Table 1.
Characteristics of neutrophil to CD4+ lymphocyte ratio in patients with COVID-19 pneumonia.
| Variable (unit, normal range) | Total (n = 95) | ≤ 0.012533 (n = 48) | > 0.012533 (n = 47) | P value |
|---|---|---|---|---|
| Female, No. (%) | 51 (53.6) | 34 (70.8) | 17 (36.2) | 0.001 |
| Age, mean ± SD | 55 ± 16 | 50 ± 15 | 60 ± 16 | 0.006 |
| Comorbidities, No. (%) | ||||
| Cardiovascular/cerebrovascular | 28 (29.4) | 11 (22.9) | 17 (36.2) | 0.157 |
| Respiratory | 6 (6.3) | 1 (2.1) | 5 (10.6) | 0.111 |
| Endocrine | 23 (24.2) | 10 (20.8) | 13 (27.6) | 0.437 |
| Nervous | 3 (3.1) | 1 (2.1) | 2 (4.2) | 0.617 |
| Urinary | 1 (1.1) | 0 (0) | 1 (2.1) | 0.495 |
| Hepatic | 8 (8.4) | 4 (8.3) | 4 (8.5) | 1.000 |
| Symptoms and signs, No. (%) | ||||
| Fever | 64 (67.3) | 27 (56.2) | 37 (78.7) | 0.020 |
| Fatigue | 32 (33.6) | 8 (16.7) | 24 (51.1) | P < 0.001 |
| Headache | 2 (2.1) | 2 (4.2) | 0 (0) | 0.495 |
| Cough | 36 (37.8) | 14 (29.2) | 22 (46.8) | 0.076 |
| Chest distress/breath shortness | 36 (37.8) | 8 (16.7) | 28 (59.6) | P < 0.001 |
| Anorexia | 2 (2.1) | 0 (0) | 2 (4.2) | 0.242 |
| Diarrhea | 1 (1.1) | 1 (2.1) | 0 (0) | 1.000 |
| Severity assessment on admission, No. (%) | ||||
| General | 56 (58.9) | 40 (83.3) | 16 (34.0) | P < 0.001 |
| Serious | 15 (15.8) | 6 (12.5) | 9 (19.1) | |
| Critical | 24 (25.2) | 2 (4.2) | 22 (46.8) | |
| Hospitalized treatment, No. (%) | ||||
| Corticosteroid | 58 (61.1) | 19 (39.6) | 39 (82.9) | P < 0.001 |
| Mechanical ventilation | 23 (24.2) | 2 (4.2) | 21 (44.7) | P < 0.001 |
| Virus negative conversion time, median (IQR) | 19 (11–27) | 13 (9–21) | 24 (18–33) | P < 0.001 |
Abbreviation: COVID-19, coronavirus disease 2019; No., number; SD, standard deviation; IQR, interquartile range.